ArticlePharmaceuticals (Basel, Switzerland)2026
Cycloastragenol Attenuates Angiotensin II-Induced Cardiac Remodeling in Association with Enhanced EGFR Lysosomal Turnover and Changes in MAPK Signaling and Autophagy.
Dongsheng Wei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.